Silo Pharma annual revenue
2019
2020
2022
2023
2024
2025
Silo Pharma reported $72,102 in revenue for fiscal 2025, an increase of 0.00% from the previous fiscal year.
View full Silo Pharma company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $72,102 | $0 | 0.00% |
| 2024 | 2024-12-31 | $72,102 | $0 | 0.00% |
| 2023 | 2023-12-31 | $72,102 | $0 | 0.00% |
| 2022 | 2022-12-31 | $72,102 | — | — |
| 2020 | 2020-12-31 | $40,923 | $354 | +0.87% |
| 2019 | 2019-12-31 | $40,569 | — | — |
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | −$18,025 | −100.00% |
| Q1 2026 | 2026-03-31 | $18,026 | $0 | 0.00% |
| Q4 2025 | 2025-12-31 | $18,026 | $0 | 0.00% |
| Q3 2025 | 2025-09-30 | $18,025 | $0 | 0.00% |
| Q2 2025 | 2025-06-30 | $18,025 | $0 | 0.00% |
| Q1 2025 | 2025-03-31 | $18,026 | $0 | 0.00% |
| Q4 2024 | 2024-12-31 | $18,026 | $0 | 0.00% |
| Q3 2024 | 2024-09-30 | $18,025 | $0 | 0.00% |
| Q2 2024 | 2024-06-30 | $18,025 | $0 | 0.00% |
| Q1 2024 | 2024-03-31 | $18,026 | $0 | 0.00% |
| Q4 2023 | 2023-12-31 | $18,026 | — | — |
| Q3 2023 | 2023-09-30 | $18,025 | $0 | 0.00% |
| Q2 2023 | 2023-06-30 | $18,025 | $0 | 0.00% |
| Q1 2023 | 2023-03-31 | $18,026 | — | — |
| Q3 2022 | 2022-09-30 | $18,025 | — | — |
| Q2 2022 | 2022-06-30 | $18,025 | −$50,060 | −73.53% |
| Q2 2021 | 2021-06-30 | $68,085 | $65,869 | +2972.43% |
| Q1 2021 | 2021-03-31 | $47,433 | $47,139 | +16033.67% |
| Q4 2020 | 2020-12-31 | $22,128 | — | — |
| Q3 2020 | 2020-09-30 | $16,285 | $16,017 | +5976.49% |
| Q2 2020 | 2020-06-30 | $2,216 | — | — |
| Q1 2020 | 2020-03-31 | $294 | — | — |
| Q3 2019 | 2019-09-30 | $268 | — | — |
Over the last five reported fiscal years, revenue grew from $40,923 to $72,102, a compound annual growth rate of 11.99%. Silo Pharma's latest reported quarter, Q2 2026, generated $0 in revenue, a decrease of 100.00% year over year.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Silo Pharma source filings ↗